Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Maron, R.
Right arrow Articles by Weiner, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maron, R.
Right arrow Articles by Weiner, H. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 14, No. 2, 131-138, February 2002
© 2002 Japanese Society for Immunology

Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines

Ruth Maron, Anthony J. Slavin, Ethan Hoffmann, Yoshinori Komagata and Howard L. Weiner

Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA

Correspondence to: H. L. Weiner; E-mail: hweiner{at}rics.bwh.harvard.edu

Oral tolerance to myelin basic protein (MBP) is an effective antigen-specific method to suppress experimental allergic encephalomyelitis (EAE). Glatiramer acetate [copolymer 1 (Cop1)] is a synthetic copolymer designed to mimic MBP which suppresses EAE, is used parenterally to treat multiple sclerosis (MS) and is being tested orally for efficacy in MS. We investigated the immunologic properties of Cop1 to determine the degree to which its effects were antigen specific using MBP TCR transgenic mice. Immunization of MBP TCR transgenic mice fed Cop1, MBP or MBP Ac1–11 resulted in decreased proliferation, and IL-2, IL-6 and IFN-{gamma} production, and increased secretion of IL-10 and transforming growth factor (TGF)-ß in Cop1-fed animals. IFN-{gamma} was decreased, and IL-10 and TGF-ß were increased in non-immunized mice fed Cop1 and stimulated in vitro with MBP. No such effects were observed in ovalbumin TCR transgenic mice. To determine if the effects of Cop1 were specific to MBP TCR-bearing cells, MBP TCR transgenic Rag2–/– mice were immunized and re-stimulated in vitro with Cop1. We found a marked increase in IL-4 and similar increases in IL-4 after feeding Cop1. In disease models, feeding Cop1 suppressed EAE in MBP TCR transgenic mice, (PL/J x SJL)F1 mice, and in myelin oligodendrocyte glycoprotein-induced EAE in NOD mice. Oral Cop1 had no effect on collagen-induced arthritis. These results demonstrate that Cop1 is active orally in an antigen-specific fashion, and may function as an altered peptide ligand for MBP-specific TCR-bearing cells by decreasing pro-inflammatory cytokines (IFN-{gamma}) and increasing anti-inflammatory cytokines (IL-4, IL-10 and TGF-ß).

Keywords: anti-inflammatory cytokines, copolymer 1, experimental allergic encephalomyelitis, myelin basic protein, oral tolerance, transforming growth factor-ß


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
G.H.M. van Puijvelde, A.D. Hauer, P. de Vos, R. van den Heuvel, M.J.C. van Herwijnen, R. van der Zee, W. van Eden, T.J.C. van Berkel, and J. Kuiper
Induction of Oral Tolerance to Oxidized Low-Density Lipoprotein Ameliorates Atherosclerosis
Circulation, October 31, 2006; 114(18): 1968 - 1976.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Husted
Structural insight into the role of myelin basic protein in multiple sclerosis
PNAS, March 21, 2006; 103(12): 4339 - 4340.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. J. Mekala, R. S. Alli, and T. L. Geiger
IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes
PNAS, August 16, 2005; 102(33): 11817 - 11822.
[Abstract] [Full Text] [PDF]


Home page
Exp Biol MedHome page
J. D. Lutton, R. Winston, and T. C. Rodman
Multiple Sclerosis: Etiological Mechanisms and Future Directions
Exp Biol Med, January 1, 2004; 229(1): 12 - 20.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. H. Salama, J. Hong, Y. C. Q. Zang, A. El-Mongui, and J. Zhang
Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis
Brain, December 1, 2003; 126(12): 2638 - 2647.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.